Stock SOLV SOLVENTUM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Solventum Corporation

Equities

SOLV

US83444M1018

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
59.32 USD +1.66% Intraday chart for Solventum Corporation -1.87% -.--%
May. 30 Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target MT
May. 09 Solventum Q1 Adjusted Earnings Decline, Net Sales Increase MT

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 10,249 - -
Enterprise Value (EV) 1 17,410 16,856 16,053
P/E ratio 15.5 x 14.9 x 11.7 x
Yield - - -
Capitalization / Revenue 1.26 x 1.25 x 1.22 x
EV / Revenue 2.15 x 2.06 x 1.92 x
EV / EBITDA 8.18 x 7.97 x 7.64 x
EV / FCF 22.8 x 19 x 16.7 x
FCF Yield 4.39% 5.25% 5.98%
Price to Book 2.54 x 2.27 x 1.9 x
Nbr of stocks (in thousands) 172,710 - -
Reference price 2 59.34 59.34 59.34
Announcement Date - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 - 8,109 8,180 8,367
EBITDA 1 - 2,127 2,116 2,100
EBIT 1 - 1,758 1,627 1,674
Operating Margin - 21.68% 19.89% 20%
Earnings before Tax (EBT) 1 1,667 917 1,008 1,105
Net income 1 1,346 905 919 878
Net margin - 11.16% 11.23% 10.49%
EPS 2 - 3.825 3.980 5.090
Free Cash Flow 1 - 764.5 885.5 960.5
FCF margin - 9.43% 10.82% 11.48%
FCF Conversion (EBITDA) - 35.94% 41.85% 45.73%
FCF Conversion (Net income) - 84.48% 96.36% 109.4%
Dividend per Share 2 - - - -
Announcement Date 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,016 2,055 2,020 2,002 2,005
EBITDA 1 520 528.2 549.5 480.8 544.5
EBIT 1 484 440.9 444.1 384 387.9
Operating Margin 24.01% 21.45% 21.98% 19.18% 19.35%
Earnings before Tax (EBT) - - - - -
Net income 1 - 231 287.6 203.4 234.8
Net margin - 11.24% 14.24% 10.16% 11.71%
EPS 2 - 0.6300 0.9600 0.4700 0.8100
Dividend per Share - - - - -
Announcement Date 5/9/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - 7,162 6,607 5,804
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - 3.367 x 3.123 x 2.764 x
Free Cash Flow 1 - 765 886 961
ROE (net income / shareholders' equity) - 21.2% 23.3% 23%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 23.40 26.20 31.20
Cash Flow per Share 2 - 6.940 8.750 -
Capex 1 - 450 450 450
Capex / Sales - 5.55% 5.5% 5.38%
Announcement Date 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
59.34 USD
Average target price
65.75 USD
Spread / Average Target
+10.80%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
SOLVENTUM CORPORATION Stock Solventum Corporation
-.--% 10.25B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 88.99B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-5.56% 25.03B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.88B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.43B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.77B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.21B
NATERA, INC. Stock Natera, Inc.
+70.11% 13.08B
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. SOLV Stock
  4. Financials Solventum Corporation